Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2020-02-13 2017-03-13
Drug Identification Number 02405083 02405083
Brand name EPTIFIBATIDE INJECTION EPTIFIBATIDE INJECTION
Common or Proper name EPTIFIBATIDE EPTIFIBATIDE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients EPTIFIBATIDE EPTIFIBATIDE
Strength(s) 0.75MG 0.75MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100ML 100ML
ATC code B01AC B01AC
ATC description ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-11-01 2016-11-01
Estimated end date Unknown
Actual end date 2017-03-03
Shortage status Resolved Actual shortage
Company comments Product Discontinued.
Health Canada comments